Phannacokinetics of Active Component of Chrysanthemum Morifolium Extracts and Its Acid Hydrolysate in Rabbits

LI Li-ping,JIANG Hui-di,WU Hao-hao,CHEN Ting
DOI: https://doi.org/10.3321/j.issn:1001-2494.2005.24.014
2005-01-01
Abstract:OBJECTIVE To characterize and compare the metabolic pharmacokinetics of the active components (luteolin and apigenin) in rabbit after an oral administration of acid hydrolysate of Chrysanthemum morifolium extracts (CME) or intact CME, and clarify whether the bioavailability of flavoloids from Chrysanthemum morifolium Ramat. would be modified due to the preparation of flavonoids forms.METHODS The concentrations of luteolin and apigenin in plasma were determined by HPLC method after a single oral dose of 200 mg·kg-1 of intact CME and hydrolysate of CME was administered to rabbits. The pharmacokinetic parameters were calculated by software 3P87 and statistical analysis was performed by software Microsoft Excel. RESULTS The plasma concentration of luteolin was determined accurately and the pharmacokinetic profile was discribed by an one-compartment model. However, the present study showed that the concentration of apigenin was too low to be measured accurately. There were some differences in pharmacokinetic parameters for active component (luteolin) between the hydrolysate of CME and intact CME apparently. Furthermore, the oral hydrolysate of CME resulted in a delayed tmax, lower ρmax and longer MRT (mean residence time) for luteolin than those after an oral dose of intact CME.CONCLUSION By statistical analysis, the bioavailability of luteolin reveals no significant difference (P0.05) after an oral administration of acid hydrolysate of CME or intact CME to rabbit.
What problem does this paper attempt to address?